Indoco Remedies receives US-FDA tentative approval for canagliflozin tablets
Indoco Remedies Ltd. announced the receipt of tentative US FDA approval for Abbreviated New Drug Application (ANDA) for canagliflozin tablets 100 mg and 300 mg, a generic equivalent of the Reference Listed Drug, Invokana tablets 100 mg and 300 mg, of Janssen Pharmaceuticals, Inc.
This product will be manufactured by Indoco Remedies Limited, at their manufacturing facility located at Goa (Plant -I) in India.
Canagliflozin improves glycemic control in adults with type 2 diabetes mellitus.
Commenting on the achievement, Aditi Panandikar, managing director said, “Besides reflecting the capability of Indoco Remedies to deliver products of high-quality standards, this development also provides impetus to our growth aspirations in an important market such as the US.”
Indoco is a fully integrated, research-oriented pharmaceutical company with presence in 55 countries. The Company’s turnover is US$ 200 million with a human capital of 6,000 employees, including over 400 skilled scientists and field staff who are the strength of the organization.

Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!